Synthetic Biology Market 2018 Global Trend, Segmentation And Opportunities Forecast To 2023

Synthetic Biology
Wiseguyreports.Com Adds “Synthetic Biology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Synthetic Biology Industry

Description

DNA is an industrial and medical wonder material of the 21st Century: This polymer is the core material of synthetic biology. Synthetic biology encompasses all aspects of DNA, including its reading, writing, and editing. For example, DNA editing tools like CRISPR or zinc finger nucleases are changing synthetic biology and driving market applications and growth.

These tools enable both development of novel cell lines and synthesis of important proteins. The combination of gene-editing tools and host engineering platforms enables development of new proteins more effectively.

Innovations in CRISPR gene editing tools promise to transform this field, including nano-particle delivery of CRISPR systems (MIT) and non-Cas9 gene editing.

In November 2017 Sangamo, a gene editing company, announced treatment of the first patient to undergo in-vivo gene editing for Hunters Syndrome. This was the first time that a patient received therapy to edit DNA of cells directly inside of the body. This marked a new era in gene editing because the edited DNA is integrated permanently into the patient’s DNA. Sangamo’s in vivo gene editing product candidates have received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration.

This report examines the dynamic synthetic-biology industry, including its technologies and global markets, and notes the leading companies in each of the market segments.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2820006-synthetic-biology-global-markets

The synthetic-biology industry consists of three main sets of technologies and products: enabling, core and enabled. Enabling technologies and products are the engine that drives the development of the synthetic biology industry. Core products and technologies—standardized DNA parts, synthetic genes and chassis organisms—are the key tools by which cellular factories and systems produce enabled products.

Products enabled by synthetic biology tools—pharmaceuticals, chemicals, biofuels and agricultural— have large downstream market potential. Synthetic biology technologies add value in each of these downstream industries. For example, synthetic biology has simplified the commercialization pathway for genome-edited crops in the agriculture industry and enhanced the availability, quality control and testing of novel synthetic genes in the drug development industry.Report Scope

The scope of this study includes core synthetic biology products (synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-free systems and production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, gene editing, bioinformatics and specialty media) and enabled technologies (healthcare, industrial chemicals, consumer products, food and beverages, and agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic biology technologies and products to determine present and future market status and forecasted growth from 2017 through 2022. We also discuss strategic alliances, industry structures, competitive dynamics, patents, and market-driving forces.

BCC Research examines the synthetic biology industry by market segment, including the following segments: DNA sequencing, DNA synthesis, gene editing, synthetic biology foundries, software, and the following enabled products sectors: agriculture, consumer products, cosmetics/skin care, food and beverages, healthcare, and industrial chemicals.

The role of key strategic alliances and acquisitions from 2016 through 2017 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, genome-edited crops, and chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 185 companies in these fields are highlighted.

Report Includes

– An overview of the global markets for synthetic biology 
– Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022 
– Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells 
– Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics 
– Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture 
– Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape 
– Assessments of the products and technologies most commercially viable now and in the near future 
– Company profiles of major players in the market, including Illumina, Inc, New England Biolabs, Precision Biosciences, Royal Dsm Nv, Sgi-Dna Inc., Synthetic and Genomics, Inc

Leave a Query @ https://www.wiseguyreports.com/enquiry/2820006-synthetic-biology-global-markets

 

Table of Contents 

Chapter 1 Introduction 
Chapter 2 Summary and Highlights 
Chapter 3 Overview 
Chapter 4 Market and Technology Background 
Chapter 5 Synthetic Biology Applications 
Chapter 6 Synthetic Biology Industry 
Chapter 7 Synthetic Biology Markets 
Chapter 8 Patents 
Chapter 9 Synthetic Biology Company Profiles 
20N LABS INC. 
ABEONA THERAPEUTICS INC. 
ACTIVE MOTIF 
AEMETIS INC. 
AGENOVIR 
AGERIA 
AGILENT TECHNOLOGIES INC. 
AGILIS BIOTHERAPEUTICS LLC 
AGRIMETIS LLC 
AGRIVIDA 
ALGENUITY 
AMBRX INC. 
AMYRIS INC. 
ANTHEIA INC. 
ARAKNITEK 
ARANEX BIOTECH 
ARDRA BIO INC. 
ARZEDA CORP. 
ASTRAZENECA PLC 
ATG BIOSYNTHETICS GMBH 
ATUM 
AVA FOOD LABS INC. 
AVIDBIOTICS CORP. 
AZARGEN BIOTECHNOLOGIES PTY LTD. 
AZITRA INC. 
BASF AG 
BAYER AG 
BELL BIOSYSTEMS 
BENCHLING 
BETA RENEWABLES 
BIOAMBER INC. 
BIO BASIC INC. 
BIOCAPITAL HOLDINGS LLC. 
BIOCELLECTION INC. 
BIOMAX INFORMATICS AG 
BIOMX LTD. 
BIONEER CORP. 
BIO S&T INC. 
BIOSYNTIA APS 
BLUEBIRD BIO INC. 
BLUE HERON BIOTECH LLC 
BLUE MARBLE BIOMATERIALS 
BOLT THREADS 
BRISTOL-MYERS SQUIBB COMPANY 
CALYSTA INC. 
CALYXT INC. 
CARGILL, INC. 
CARIBOU BIOSCIENCES INC. 
CASZYME 
CATALOG TECHNOLOGIES INC. 
CELL DESIGN LABS 
CELLECTIS SA 
CELL FREE TECHNOLOGY LTD. 
CHAIN BIOTECHNOLOGY LTD 
CIBUS INC. 
CLARA FOODS CO. 
C-LECTA GMHB 
CODAGENIX INC. 
CODEXIS, INC. 
CORBION BIOTECH INC. 
DEMURIS LTD. 
DESKTOP GENETICS LTD. 
DNA SCRIPT 
DOWDUPONT, INC. 
EDITAS MEDICINE INC. 
EGENESIS INC. 
ELIGO BIOSCIENCE 
ENBIOTIX INC. 
ENEVOLV INC. 
EPIBIOME INC. 
EPOCH LIFE SCIENCE INC. 
EUROFINS MWG OPERON 
EVONETIX 
EVOLVA SA 
EXONICS THERAPEUTICS INC. 
EXXONMOBIL CORP. 
GEA ENZYMES 
GELTOR INC. 
GENEDESIGN, INC. 
GENEMED SYNTHESIS, INC. 
GENE ORACLE INC. 
GENERAY BIOTECH CO. LTD. 
GENOMATICA 
GENSCRIPT 
GEVO, INC. 
GINKGO BIOWORKS 
GLAXOSMITHKLINE PLC 
GLOBAL BIOENERGIES 
GLOWEE 
GLYCOSBIO FOOD SCIENCES 
GOODYEAR TIRE & RUBBER CO. 
GREEN BIOLOGICS LTD. 
HELIXWORKS TECHNOLOGIES LTD. 
HOMOLOGY MEDICINES 
HORIZON DISCOVERY GROUP PLC 
HUVEPHARMA 
ILLUMINA, INC. 
IMPOSSIBLE FOODS INC. 
INDUSTRIAL MICROBES INC. 
INGENZA LTD. 
INOVIO PHARMACEUTICALS INC. 
INTEGRATED DNA TECHNOLOGIES INC. 
INTELLIA THERAPEUTICS 
INTERNATIONAL BUSINESS MACHINES 
INTREXON CORP. 
JUNO THERAPEUTICS INC. 
KANEKA CORP. 
LABGENIUS LTD. 
LANZATECH 
LATTICE AUTOMATION INC. 
LC SCIENCES 
LOCUS BIOSCIENCES 
LUMEN BIOSCIENCE 
LYGOS INC. 
MERCK & CO. 
METAMIXIS 
MICHELIN SA 
MICROBYRE 
MICROSOFT CORP. 
MILIS BIO LTD. 
MIRACULEX 
MODERN MEADOW 
MODULAR GENETICS INC. 
MOLECULAR ASSEMBLIES INC. 
MORPHOSYS AG 
MUSE BIOTECHNOLOGY INC. 
MYRIANT CORP. 
NEW ENGLAND BIOLABS 
NOVARTIS PHARMA AG 
NOVOME BIOTECHNOLOGIES INC. 
NOVOZYMES A/S 
NOVVI LLC 
NUCELIS LLC 
NUCLERA NUCLEICS LTD. 
OMEGA BIO-TEK INC. 
ORAGENICS INC. 
OXFORD GENETICS LTD. 
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 
PERFECT DAY INC. 
PFIZER, INC. 
PHYLOGICA LTD. 
PHYTOWELT GREEN TECHNOLOGIES GMBH 
PIVOT BIO 
POSEIDA THERAPEUTICS INC. 
PRECISION BIOSCIENCES 
PROKARIUM HOLDINGS LTD. 
QTEROS INC. 
RADIANT GENOMICS INC. 
RENNOVIA INC. 
REVERDIA 
ROYAL DSM NV 
SAMPLE6 TECHNOLOGIES 
SANGAMO THERAPEUTICS INC. 
SCARAB GENOMICS LLC 
SGI-DNA INC. 
Shanghai SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC. 
SIGMA ALDRICH CORP. 
SILICOLIFE LDA. 
SOLIGENIX INC. 
SPIBER INC. 
STRING BIO 
SUGARLOGIX 
SYNBIOTA 
SYNBIO TECHNOLOGIES CO., LTD. 
SYNLOGIC 
SYNPROMICS LTD. 
SYNTHACE LTD. 
SYNTHEGO CORP. 
SYNTHETIC BIOLOGICS INC. 
SYNTHETIC GENOMICS, INC. 
SYNTHORX INC. 
SYNVITROBIO INC. 
TAXA BIO-ENGINEERING 
TEEWINOT LIFE SCIENCES CORP. 
TEPHA, INC. 
TESELAGEN BIOTECHNOLOGY INC. 
THERMO FISHER SCIENTIFIC, INC. 
TRANSCRIPTIC, INC. 
TRITON ALGAE INNOVATIONS LTD. 
TWIST BIOSCIENCE 
TYSON FOODS INC. 
UBA BIOLOGIX 
VEDANTA BIOSCIENCES 
VERDEZYNE INC. 
XYCROBE THERAPEUTICS INC. 
YIELD10 BIOSCIENCES 
ZIOPHARM ONCOLOGY INC. 
ZYMERGEN 
ZYMOCHEM INC.

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2820006

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

 

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/2820006-synthetic-biology-global-markets